These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
164 related items for PubMed ID: 8275443
1. Prognostic significance of the blast self-renewal capacity in patients with acute myeloid leukemia. Nara N, Kurokawa H, Tanikawa S, Tomiyama J, Nagata K. Cancer; 1994 Jan 01; 73(1):92-7. PubMed ID: 8275443 [Abstract] [Full Text] [Related]
2. The in vitro growth patterns and drug sensitivities of leukemic blast progenitors among the subtypes of acute myelocytic leukemia. Nara N, Chen GJ, Murohashi I, Tohda S, Imai Y, Tomiyama J, Nagata K, Suzuki T, Tanikawa S, Shiina S. Exp Hematol; 1992 Aug 01; 20(7):904-8. PubMed ID: 1628709 [Abstract] [Full Text] [Related]
5. In vitro and in vivo effects of 5-aza-2'-deoxycytidine (Decitabine) on clonogenic cells from acute myeloid leukemia patients. Gattei V, Aldinucci D, Petti MC, Da Ponte A, Zagonel V, Pinto A. Leukemia; 1993 May 01; 7 Suppl 1():42-8. PubMed ID: 7683356 [Abstract] [Full Text] [Related]
7. Comparison of the proliferative activity and sensitivity to cytosine arabinoside of leukemic blast progenitors in acute myeloblastic leukemia at diagnosis and in relapse. Nara N, Tohda S, Suzuki T, Nagata K, Tanikawa S, Imai Y, Tomiyama J, Shiina S. Acta Haematol; 1992 May 01; 88(1):17-21. PubMed ID: 1414157 [Abstract] [Full Text] [Related]
14. Effect of platelet-derived growth factor on the proliferation of blast progenitors from acute myeloblastic leukemia patients. Nara N, Tohda S, Nagata K, Suzuki T, Yamashita Y, Imai Y. Acta Haematol; 1990 May 01; 83(4):187-92. PubMed ID: 2115715 [Abstract] [Full Text] [Related]
15. In vitro sensitivity of hematopoietic progenitors to tiazofurin in refractory acute myeloid leukemia and in the blast crisis of chronic myeloid leukemia. Colovic M, Sefer D, Bogdanovic A, Suvajdzic N, Jankovic G, Atkinson HD, Milenkovic P. Cancer Lett; 2003 Jun 10; 195(2):153-9. PubMed ID: 12767523 [Abstract] [Full Text] [Related]
16. Cytotoxicity of 4-hydroperoxycyclophosphamide for the blast progenitors of acute myeloblastic leukemia. Nara N, Suzuki T, Yamashita Y, Murohashi I, Aoki N. Cancer Res; 1988 May 01; 48(9):2348-52. PubMed ID: 3162711 [Abstract] [Full Text] [Related]
17. Inhibition of the in vitro growth of blast progenitors from acute myeloblastic leukemia patients by transforming growth factor-beta (TGF-beta). Nara N, Tohda S, Nagata K, Suzuki T, Yamashita Y. Leukemia; 1989 Aug 01; 3(8):572-7. PubMed ID: 2473359 [Abstract] [Full Text] [Related]
18. Effect of melphalan against self-renewal capacity of leukemic progenitors in acute myeloblastic leukemia. Demur C, Chiron M, Saivin S, Attal M, Dastugue N, Bousquet C, Galinier JL, Colombies P, Laurent G. Leukemia; 1992 Mar 01; 6(3):204-8. PubMed ID: 1564957 [Abstract] [Full Text] [Related]
19. The effect of basic and acidic fibroblast growth factors (bFGF and aFGF) on the growth of leukemic blast progenitors in acute myelogenous leukemia. Nara N, Kurokawa H, Tohda S, Tomiyama J, Nagata K, Tanikawa S. Exp Hematol; 1995 Aug 01; 23(9):1030-4. PubMed ID: 7543415 [Abstract] [Full Text] [Related]
20. Effect of vesnarinone, a quinolinone derivative, on the growth of leukemic blasts in acute myelogenous leukemia. Nara N, Kurokawa H, Tohda S, Tomiyama J, Nagata K, Tanikawa S. Exp Hematol; 1997 Mar 01; 25(3):199-204. PubMed ID: 9091294 [Abstract] [Full Text] [Related] Page: [Next] [New Search]